ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY
Tes Pharma Will Use the elive™ Platform to Functionally Evaluate Response to TES-4207 in Live Tumor Fragments as a Monotherapy and in Combination With Immune Checkpoint Inhibitors MADISON, Wis., Sept. 24, 2026 /PRNewswire/ -- Elephas Biosciences Corporation, developer of a functional...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Best Prenatal Vitamin Powder (2026): Needed Named The Top Easy-to-Take Powder Prenatal by Consumer 365
- Duke Energy board appoints Joyce Mullen as new member
- HealthTech Partners Global Expands Rehabilitation Technology Portfolio with Two New Strategic Partnerships and Launch of Boston Service Operations Hub
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →